# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-26-016544
Filing Date
2026-04-14
Accepted
2026-04-14 16:06:09
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | formdefa14a.htm | DEFA14A | 15181
2 | GRAPHIC | formdefa14a_001.jpg | GRAPHIC | 446487
3 | GRAPHIC | formdefa14a_002.jpg | GRAPHIC | 511963
| Complete submission text file | 0001493152-26-016544.txt |  | 1336715

Mailing Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET RIVERVIEW II 18TH FLOOR CAMBRIDGE MA 02142 (617) 444-8400
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38286 | Film No.: 26860881
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)